Belpointe Asset Management LLC Ionis Pharmaceuticals Inc Transaction History

Belpointe Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $2,014 - $2,472	-60 Reduced 9.87%	548 $19,000
Q4 2022 Feb 08, 2023	BUY	$37.12 - $46.52 $22,568 - $28,284	608 New	608 $22,000
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $76,900 - $115,378	-1,809 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $81,947 - $109,028	1,809 New	1,809 $102,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $87,545 - $116,142	-1,845 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$46.85 - $61.05 $86,438 - $112,637	1,845 New	1,845 $109,000
Q2 2019 Nov 22, 2019	SELL	$62.09 - $86.14 $91,458 - $126,884	-1,473 Closed	0 $0
Q1 2019 Jun 11, 2019	BUY	$52.92 - $81.17 $77,951 - $119,563	1,473 New	1,473 $120,000

410

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.46B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.